Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Maturity and density of tertiary lymphoid structures associate with tumor metastasis and chemotherapy response
Sutian Jiang, Xuhui Liao, Xuzhong Ding
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Dynamics of Liver Cancer Cellular Taxa Revealed Through Single-cell RNA Sequencing: advances and challenges
Wenxin Li, Huisi He, Hongyang Wang, et al.
Cancer Letters (2024), pp. 217394-217394
Closed Access | Times Cited: 1
Whole-genome sequencing of 20 cholangiocarcinoma cases reveals unique profiles in patients with cirrhosis and primary sclerosing cholangitis
Nicholas Holzapfel, Amy Zhang, Woojin Choi, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 379-389
Open Access | Times Cited: 3
Dissecting the tumor ecosystem of liver cancers in the single-cell era
Yue Wang, Pengxiang Wang, Zefan Zhang, et al.
Hepatology Communications (2023) Vol. 7, Iss. 9
Open Access | Times Cited: 3
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma
Weiren Liu, Huqiang Wang, Qianfu Zhao, et al.
Cancer Communications (2023) Vol. 44, Iss. 2, pp. 226-250
Open Access | Times Cited: 3
Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma
Zixue Xuan, Linqing Liu, Guobing Zhang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130420-130420
Closed Access | Times Cited: 2
Immunogenomics of cholangiocarcinoma
Virag Gehl, Colm J. O’Rourke, Jesper B. Andersen
Hepatology (2023)
Closed Access | Times Cited: 2
Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Distinct Subgroups and Proteins Associated with Time-To-Recurrence
Tilman Werner, Klara-Luisa Budau, Miguel Cosenza-Contreras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Heterogeneity in Liver Cancer Immune Microenvironment: Emerging Single-Cell and Spatial Perspectives
Caiyi Cherry Li, Meng Liu, Hsin-Pei Lee, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 133-146
Closed Access
Zanthoxylum zanthoxyloides (Lam.) B. Zepernick & Timler alkaloidal extract exerts hepatoprotective effects in rats with a CCl4/olive oil-induced hepatocellular carcinoma-like phenotype
Alex Boye, Victor A. Barku, Justice Kwaku Addo, et al.
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 4, pp. 753-765
Open Access
Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies
Yidan Lou, Yijing Chen, Kaibo Guo, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 15-16, pp. 703-715
Closed Access
Tertiary Lymphoid Structures in Microorganism-Related Cancer
Shuzhe Deng, Xinxin Yang, Lin He, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3464-3464
Open Access
The prognostic significance of FoxM1 and its immune regulatory function in Liver Hepatocellular Carcinoma
Changyou Li, Qi Yao, Cunhai Chen, et al.
Research Square (Research Square) (2024)
Open Access
Supplementary Methods from Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers
Haotian Liao, Xing Chen, Haichuan Wang, et al.
(2024)
Open Access
Supplementary Methods from Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers
Haotian Liao, Xing Chen, Haichuan Wang, et al.
(2024)
Open Access
Multi-Omics Classification of Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
Laura Alaimo, Sara Boggio, Giovanni Catalano, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2596-2596
Open Access
Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma
Hao Jiang, Biao Gao, Zihe Meng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function Through Shared and Distinct Pathways
Ian C. Henrich, Ngan Nguyen
Molecular Cancer Research (2024) Vol. 23, Iss. 2, pp. 155-168
Closed Access
Online Alkaline-pH Reverse Phase Nanoelectrospray-Tandem Mass Spectrometry Complements Conventional Low-pH Method for Global Proteomic Analysis
Jing Gao, Yuqiu Wang, Shu Zhang, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 5, pp. 1446-1454
Closed Access | Times Cited: 1
Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes
Chaoqun Li, Lei Bie, Muhua Chen, et al.
Exploration of Targeted Anti-tumor Therapy (2023) Vol. 4, Iss. 6, pp. 1310-1327
Open Access | Times Cited: 1
Targeted mutation-based therapy for intrahepatic cholangiocarcinoma
Facai Yang, Yinghe Qiu, Bin Yi
Hepatoma Research (2023)
Open Access
Previous Page - Page 2

Scroll to top